These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 2550544

  • 1. Coxsackievirus-B3-induced myocarditis: virus receptor antibodies modulate myocarditis.
    Weller AH, Simpson K, Herzum M, Van Houten N, Huber SA.
    J Immunol; 1989 Sep 15; 143(6):1843-50. PubMed ID: 2550544
    [Abstract] [Full Text] [Related]

  • 2. Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis.
    Gauntt CJ, Arizpe HM, Higdon AL, Wood HJ, Bowers DF, Rozek MM, Crawley R.
    J Immunol; 1995 Mar 15; 154(6):2983-95. PubMed ID: 7533190
    [Abstract] [Full Text] [Related]

  • 3. T lymphocyte responses in CVB3-induced murine myocarditis.
    Huber S, Polgar J, Moraska A, Cunningham M, Schwimmbeck P, Schultheiss P.
    Scand J Infect Dis Suppl; 1993 Mar 15; 88():67-78. PubMed ID: 7685923
    [Abstract] [Full Text] [Related]

  • 4. [Experimental comparison of two coxsackievirus B3 variants in murine myocardial cells].
    Cui X, Gomez R, Sun G, Ma L, Xu Z.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep 15; 11(3):274-6. PubMed ID: 15617347
    [Abstract] [Full Text] [Related]

  • 5. Coxsackievirus B-3-induced myocarditis. Virus and actinomycin D treatment of myocytes induces novel antigens recognized by cytolytic T lymphocytes.
    Huber SA, Heintz N, Tracy R.
    J Immunol; 1988 Nov 01; 141(9):3214-9. PubMed ID: 2459248
    [Abstract] [Full Text] [Related]

  • 6. Murine natural killer cells limit coxsackievirus B3 replication.
    Godeny EK, Gauntt CJ.
    J Immunol; 1987 Aug 01; 139(3):913-8. PubMed ID: 3036947
    [Abstract] [Full Text] [Related]

  • 7. Immunopathogenesis of experimental Coxsackievirus induced myocarditis: role of autoimmunity.
    Huber SA, Lyden DC, Lodge PA.
    Herz; 1985 Feb 01; 10(1):1-7. PubMed ID: 2984097
    [Abstract] [Full Text] [Related]

  • 8. Involvement of natural killer cells in coxsackievirus B3-induced murine myocarditis.
    Godeny EK, Gauntt CJ.
    J Immunol; 1986 Sep 01; 137(5):1695-702. PubMed ID: 3018079
    [Abstract] [Full Text] [Related]

  • 9. Antigen-specific suppressor T cells prevent cardiac injury in Balb/c mice infected with a nonmyocarditic variant of coxsackievirus group B, type 3.
    Estrin M, Smith C, Huber S.
    Am J Pathol; 1986 Dec 01; 125(3):578-84. PubMed ID: 2432792
    [Abstract] [Full Text] [Related]

  • 10. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
    Schmidtke M, Merkle I, Klingel K, Hammerschmidt E, Zautner AE, Wutzler P.
    J Med Virol; 2007 Sep 01; 79(9):1334-42. PubMed ID: 17607777
    [Abstract] [Full Text] [Related]

  • 11. Effects of in vivo administration of anti-B7-1/B7-2 monoclonal antibodies on the survival of mice with chronic ongoing myocarditis caused by Coxsackievirus B3.
    Seko Y, Takahashi N, Yagita H, Okumura K, Azuma M, Yazaki Y.
    J Pathol; 1999 May 01; 188(1):107-12. PubMed ID: 10398149
    [Abstract] [Full Text] [Related]

  • 12. Coxsackievirus B3-induced myocarditis in MHC class II-deficient mice.
    Leipner C, Borchers M, Merkle I, Stelzner A.
    J Hum Virol; 1999 May 01; 2(2):102-14. PubMed ID: 10225212
    [Abstract] [Full Text] [Related]

  • 13. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice.
    Huber SA.
    Lab Invest; 1997 May 01; 76(5):691-701. PubMed ID: 9166288
    [Abstract] [Full Text] [Related]

  • 14. Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis.
    Horwitz MS, La Cava A, Fine C, Rodriguez E, Ilic A, Sarvetnick N.
    Nat Med; 2000 Jun 01; 6(6):693-7. PubMed ID: 10835688
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
    Song X, Liu Z, Wang H, Xin Y, Wang X, Chen J, Shi Y, Zhang C, Hui R.
    Exp Biol Med (Maywood); 2007 Dec 01; 232(11):1441-8. PubMed ID: 18040068
    [Abstract] [Full Text] [Related]

  • 18. Cytolytic cross-reactive antibodies directed against the cardiac membrane and viral proteins in coxsackievirus B3 and B4 myocarditis. Characterization and pathogenetic relevance.
    Maisch B, Bauer E, Cirsi M, Kochsiek K.
    Circulation; 1993 May 01; 87(5 Suppl):IV49-65. PubMed ID: 8485834
    [Abstract] [Full Text] [Related]

  • 19. Coxsackievirus B3 infection induced viral myocarditis by regulating the expression pattern of chemokines in cardiac myocytes.
    Shen Y, Kan QC, Xu W, Chu YW, Xiong SD.
    Iran J Allergy Asthma Immunol; 2009 Mar 01; 8(1):1-9. PubMed ID: 19279353
    [Abstract] [Full Text] [Related]

  • 20. Anti-Coxsackievirus B3 neutralizing antibodies with pathological potential.
    Gauntt CJ, Arizpe HM, Higdon AL, Rozek MM, Crawley R, Cunningham MW.
    Eur Heart J; 1991 Aug 01; 12 Suppl D():124-9. PubMed ID: 1717270
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.